GlycoErase™ ALG6 Knockout Human Osteosarcoma Cell 143B (CAT#: GLJF-0525-JF133)

Description	The ALG6 knockout 143B cell line proves effective for investigating the initiation of N-glycosylation; the absence of ALG6 impairs early N-glycosylation steps, potentially leading to protein misfolding, thus allowing researchers to study the roles of N-glycosylation disorders in bone sarcoma cell proliferation, migration, drug responsiveness, and to devise drugs targeting specific pathway components.
Product Type	KO Cell Lines
Species	Human
Cell Morphology	Epithelial-like, adherent
Passage Ratio	1:2~1:3
Cell Line	143B
Primary Disease	Osteosarcoma
Lineage	Bone

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	PCR, Sanger Sequencing
Culture Medium	Bromodeoxyuridine & EMEM & FBS & Glutamine
Application	Functional assay
Size	1 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	ALG6
Full Name	ALG6 alpha-1,3-glucosyltransferase
Alternative Name	CDG1C
Location	1p31.3
Gene ID	29929
Summary	Catalyzes the first glucose addition to the lipid-linked oligosaccharide precursor in N-linked glycosylation; a critical early step in this essential protein modification process.